[1]张明蕊,范焕芳,陈佳琪,等.中医药调控铁死亡治疗非小细胞肺癌研究进展[J].陕西中医,2025,46(4):572-576.[doi:DOI:10.3969/j.issn.1000-7369.2025.04.030]
　ZHANG Mingrui,FAN Huanfang,CHEN Jiaqi,et al.Research progress of Chinese medicine regulating iron death in treatment of non-small cell lung cancer[J].,2025,46(4):572-576.[doi:DOI:10.3969/j.issn.1000-7369.2025.04.030]
点击复制

中医药调控铁死亡治疗非小细胞肺癌研究进展
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
46
期数:
2025年4期
页码:
572-576
栏目:
综 述
出版日期:
2025-04-05

文章信息/Info

Title:
Research progress of Chinese medicine regulating iron death in treatment of non-small cell lung cancer
作者:
张明蕊1; 范焕芳2; 3; 陈佳琪1; 马 盼2; 何 芸1; 金明哲1; 杨 柳1
(1.河北中医药大学研究生学院,河北 石家庄 050091; 2.河北中医药大学第一附属医院 河北省中医院,河北 石家庄 050011; 3.河北省浊毒证重点实验室,河北 石家庄 050011)
Author(s):
ZHANG Mingrui1; FAN Huanfang2; 3; CHEN Jiaqi1; MA Pan2; HE Yun1; JIN Mingzhe1; YANG Liu1
(1.Hebei University of Chinese Medicine Graduate College,Shijiazhuang 050091,China; 2.The First Hospital of Hebei University of Chinese Medicine,Shijiazhuang 050011,China; 3.Key Laboratory of Hebei Province Turbidity Toxin Syndrome,Shijiazhuang 050011,China)
关键词:
非小细胞肺癌;  中药;  铁死亡;  作用机制;  耐药;  恶性肿瘤
Keywords:
Non-small cell lung cancer;  Traditional Chinese medicine;  Ferroptosis;  Action mechanism;  Drug resistance;  Malignant tumor
分类号:
R 734.2
DOI:
DOI:10.3969/j.issn.1000-7369.2025.04.030
文献标志码:
A
摘要:
非小细胞肺癌(NSCLC)是一种具有高发病率和高病死率的恶性肿瘤,临床治愈率低,且易出现治疗耐药。铁死亡是一种特殊的铁依赖的程序性死亡方式,已有研究证实铁死亡与NSCLC的发生发展密切相关,正逐渐成为NSCLC治疗的潜力靶点。中药在恶性肿瘤的防治中具有独特优势,多种中药单体、中药活性成分及中药复方可通过铁死亡途径抑制NSCLC进展。通过总结铁死亡的发生机制,挖掘铁死亡与NSCLC之间的关联,对近年来中药在诱导铁死亡拮抗NSCLC作用机制方面的研究进展进行综述,为中药防治NSCLC提供理论支持和治疗思路。
Abstract:
Non-small cell lung cancer(NSCLC)is a malignant tumor with high morbidity and mortality.The clinical cure rate is low,and the treatment resistance is easy to occur.Ferroptosis is a special iron-dependent programmed death.Studies have confirmed that ferroptosis is closely related to the occurrence and development of NSCLC,and ferroptosis is gradually becoming a potential target for the treatment of NSCLC.Traditional Chinese medicine(TCM)has unique advantages in the prevention and treatment of malignant tumors.A variety of TCM monomers,active ingredients and compounds can inhibit the progression of NSCLC through ferroptosis pathway.This article summarizes the mechanism of ferroptosis,explores the relationship between ferroptosis and NSCLC,and reviews the research progress of the mechanism of traditional Chinese medicine in inducing ferroptosis to antagonize NSCLC in recent years,so as to provide theoretical support and treatment ideas for the prevention and treatment of NSCLC with traditional Chinese medicine.

参考文献/References:

[1] DIXON J S,LEMBERG M K,LAMPRECHT R M,et al.Ferroptosis:An iron-dependent form of nonapoptotic cell death[J].Cell,2012,149(5):1060-1072.
[2] 郭冰莲,李季,吕梦迪,等.双核芳基Os(Ⅱ)配合物的合成及诱导肿瘤铁死亡机制[J].无机化学学报,2023,39(10):1887-1897.
[3] 刘师佐,杨欢,汤蓉,等.铁死亡中的溶酶体降解系统:质量调控与能量代谢[J].中国病理生理杂志,2023,39(9):1691-1696.
[4] 赵田禾,李欣洋,孙东雷,等.铁离子与铁死亡:衰老研究领域的新大陆[J].现代预防医学,2018,45(23):4392-4395.
[5] JIANG T,CHENG H,SU J,et al.Gastrodin protects against glutamate-induced ferroptosis in HT-22 cells through Nrf2/HO-1 signaling pathway[J].Toxicol in Vitro,2020,62:104715.
[6] 李大航,徐杉,蒋丽,等.铁泵蛋白Ferroportin生理功能及其调控机制研究进展[J].生命科学,2022,34(7):754-777.
[7] LI J,CAO F,YIN H L,et al.Ferroptosis:Past,present and future[J].Cell Death Dis,2020,11(2):88.
[8] MORTENSEN M S, RUIZ J, WATTS J L.Polyunsaturated fatty acids drive lipid peroxidation during ferroptosis[J].Cells,2023,12(5):804.
[9] FENG H,STOCKWELL R B.Unsolved mysteries:How does lipid peroxidation cause ferroptosis?[J].PLoS Biol,2018,16(5):e2006203.
[10] YU S Z,ZHEN G C,LI X Y,et al.Mechanism of ferroptosis and its relationships with other types of programmed cell death:Insights for potential interventions after intracerebral hemorrhage[J].Front in Neurosci,2020,14:589042.
[11] KIRILL B,HENDRICKS J M,ZHIPENG L,et al.The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis[J].Nature,2019,575(7784):688-692.
[12] 杨铭钰,杨震,任万华.铁死亡在胆管癌中的作用机制[J].临床肝胆病杂志,2022,38(4):951-955.
[13] KRAFT V A N,BEZJIAN C T,PFEIFFER S,et al.GTP cyclohydrolase 1/tetrahydrobiopterin counteract ferroptosis through lipid remodeling[J].ACS Cent Sci,2020,6(1):41-53.
[14] 黄珊,赵漫玉,张佩景.铁死亡调控机理及其在肿瘤治疗中的应用[J].科技导报,2021,39(7):63-74.
[15] WEI D,KE Y Q,DUAN P,et al.MicroRNA-302a-3p induces ferroptosis of non-small cell lung cancer cells via targeting ferroportin[J].Free Radic Res,2021,55(7):821-830.
[16] WANG S,MA H,FANG J,et al.CircDTL functions as an oncogene and regulates both apoptosis and ferroptosis in non-small cell lung cancer cells[J].Front Genet,2021,12:743505.
[17] 陈静,张尚暖.铁死亡相关基因DPP4与肿瘤免疫及预后的生物信息学研究[J].中国免疫学杂志,2023,39(11):2348-2354,2360.
[18] FENG S L,LI Y T,HUANG H H,et al.Isoorientin reverses lung cancer drug resistance by promoting ferroptosis via the SIRT6/Nrf2/GPX4 signaling pathway[J].Eur J Pharmacol,2023,954:175853.
[19] 邓婉君,熊慧华,晁腾飞.6-磷酸葡萄糖酸脱氢酶对肺癌细胞增殖及铁死亡的影响[J].中华肿瘤防治杂志,2023,30(11):647-653.
[20] 卢天龙,杨启英,杨世闻,等.精氨酸甲基转移酶1调控铁死亡在肺癌细胞恶性生物学中的分子机制[J].实用医学杂志,2023,39(9):1098-1104.
[21] LAI Y Y,ZHANG Z P,LI J Z,et al.STYK1/NOK correlates with ferroptosis in non-small cell lung carcinoma[J].Biochem Biophys Res Commun,2019,519(4):659-666.
[22] VISWANATHAN V S,RYAN M J,DHRUV H D,et al.Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway[J].Nature,2017,547(7664):453-457.
[23] ZHANG C F,WANG C M,YANG Z Y,et al.Identification of GPX4 as a therapeutic target for lung adenocarcinoma after EGFR-TKI resistance[J].Transl Lung Cancer Res,2022,11(5):786-801.
[24] 张清峰,刘奎,杨晓燕,等.谷胱甘肽过氧化物酶4介导的铁死亡在非小细胞肺癌顺铂耐药中的作用[J].成都医学院学报,2021,16(5):587-590.
[25] LI Y,YAN H Y,XU X M,et al.Erastin/sorafenib induces cisplatin-resistant non-small cell lung cancer cell ferroptosis through inhibition of the Nrf2/xCT pathway[J].Oncolo Lett,2020,19(1):323-333.
[26] HUANG F H,PANG J L,XU L S,et al.Hedyotis diffusa injection induces ferroptosis via the Bax/Bcl2/VDAC2/3 axis in lung adenocarcinoma[J].Phytomedicine,2022,104:154319.
[27] ZHANG W,JIN J,CAO C W,et al.Combined treatment of polygonatum and Scutellaria baicalensis suppresses lung cancer cell proliferation through inducing ferroptosis[J].Phytomedicine Plus,2023,3(4):100482.
[28] LIU X F,HAI Y,DONG J Q,et al.Realgar-induced KRAS mutation lung cancer cell death via KRAS/Raf/MAPK mediates ferroptosis[J].Int J Oncol,2022,61(6):157.
[29] 李畅,王浩,贺千羽,等.槲皮素通过诱导铁死亡抑制A549细胞增殖的作用及机制研究[J].中草药,2022,53(22):7112-7120.
[30] ZHAO L P,WANG H J,HU D,et al.β-elemene induced ferroptosis via TFEB-mediated GPX4 degradation in EGFR wide-type non-small cell lung cancer[J].J Adv Res,2023,62:252-272.
[31] XU C,JIANG Z B,SHAO L,et al.β-elemene enhances erlotinib sensitivity through induction of ferroptosis by upregulating lncRNA H19 in EGFR-mutant non-small cell lung cancer[J].Pharmacolo Res,2023,191:106739.
[32] 王依蕾,洪婷,曾海荣,等.麦冬皂苷B促进细胞铁死亡抑制非小细胞肺癌A549细胞增殖的机制[J].中国医院药学杂志,2022,42(19):1983-1989.
[33] 高薇,王佳勇.基于Nrf2/HO-1通路的柴胡皂苷A对A549细胞顺铂敏感性的影响[J].中国中医药信息杂志,2023,30(1):121-127.
[34] LI J Q,HUANG S,WANG Q,et al.Andrographolide promoted ferroptosis to repress the development of non-small cell lung cancer through activation of the mitochondrial dysfunction[J].Phytomedicine,2023,109:154601.
[35] 张泽鑫,黄子怡,吴汶丰,等.生信分析鉴定青蒿素治疗非小细胞肺癌的铁死亡基因[J].广西大学学报,2021,46(5):1360-1371.
[36] SHU J L,PING L Z,HUI Z H,et al.Ginkgetin derived from Ginkgo biloba leaves enhances the therapeutic effect of cisplatin via ferroptosis-mediated disruption of the Nrf2/HO-1 axis in EGFR wild-type non-small-cell lung cancer[J].Phytomedicine,2021,80:153370.
[37] ZHOU C,YU T,ZHU R,et al.Timosaponin AⅢ promotes non-small-cell lung cancer ferroptosis through targeting and facilitating HSP90 mediated GPX4 ubiquitination and degradation[J].Int J Biol Sci,2023,19(5):1471-1489.
[38] XU F,ZHANG J T,JI L Y,et al.Inhibition of non-small cell lung cancer by ferroptosis and apoptosis induction through P53 and GSK-3β/Nrf2 signal pathways using Qingrehuoxue Formula[J].J Cancer,2023,14(3):336-349.
[39] ZHAO Y Y,YANG Y Q,SHENG H H,et al.GPX4 plays a crucial role in Fuzheng Kang'ai Decoction-induced non-small cell lung cancer cell ferroptosis[J].Front Pharmacol,2022,13:851680.
[40] 牟琪瑞,李贺,刘玥彤,等.补中益气汤通过Nrf2/ROS通路调控线粒体途径细胞凋亡改善A549/DDP细胞顺铂耐药的分子机制[J].中国实验方剂学杂志,2024,30(1):95-102.

相似文献/References:

[1]刘月芬,刘小红,于明军,等.清金化痰汤治疗非小细胞肺癌临床研究[J].陕西中医,2019,(2):229.
　LIU Yuefen,LIU Xiaohong,YU Mingjun,et al.Clinical observation of nonsmall cell lung cancer patients treated with Qingjin Huatan decoction[J].,2019,(4):229.
[2]陈姣红,古红莉,员建中,等.参术扶正抗癌汤联合化疗及三维适形放疗对晚期非小细胞肺癌患者 血清T细胞亚群水平及生存质量的影响*[J].陕西中医,2019,(5):564.
[3]张栓宝,严宁娟△,张燕平.复方斑蝥胶囊对非小细胞肺癌患者围术期血清炎症因子及免疫功能的影响[J].陕西中医,2019,(7):890.
[4]任宝中,李 媛△.益气化瘀方配合化疗治疗晚期非小细胞肺癌临床研究*[J].陕西中医,2019,(8):1036.
　REN Baozhong,LI Yuan..Application effect of TP chemotherapy Plus Yiqi Huayu decoction in advanced Non-small cell lung cancer patients[J].,2019,(4):1036.
[5]任东峰,孙国芳△.六君祛痰解毒汤联合化疗治疗非小细胞肺癌疗效〖JZ〗及对患者血管内皮生长因子的影响[J].陕西中医,2020,(1):63.
[6]张 萍,金 昕,陶 枫△.从胃肠肽角度论中药抑制食欲研究进展*[J].陕西中医,2020,(2):261.
　ZHANG Ping,JIN Xin,TAO Feng..Progress on appetite suppression of traditional Chinese medicine from the perspective of gastrointestinal peptides[J].,2020,(4):261.
[7]梁宇鹏,徐嘉敏,刘培中,等.基于数据挖掘探究新型冠状病毒性肺炎中医诊疗方案用药特点[J].陕西中医,2020,(5):567.[doi:DOI:10.3969/j.issn.10007369.2020.05.004]
[8]王立媛,王亿平,茅燕萍,等.中药优选方保留灌肠联合高位结肠透析对慢性肾衰湿热证患者CysC、PTH水平及营养的影响*[J].陕西中医,2020,(7):917.[doi:DOI:10.3969/j.issn.10007369.2020.07.023]
[9]王心怡,成晓萍.高位结肠净化联合肾康栓保留灌肠治疗非透析患者慢性肾脏病4期临床研究[J].陕西中医,2021,(1):57.[doi:DOI:10.3969/j.issn.1000-7369.2020.01.014]
[10]钟方红,皮特俊章,钟 琴,等.中药对高尿酸血症患者肠道菌群影响的研究进展[J].陕西中医,2021,(2):265.[doi:DOI:10.3969/j.issn.1000-7369.2020.02.032]
　ZHONG Fanghong,PI Tejunzhang,ZHONG Qin,et al.Research progress of the effect of traditional Chinese medicine on intestinal flora of patients with hyperuricemia[J].,2021,(4):265.[doi:DOI:10.3969/j.issn.1000-7369.2020.02.032]

备注/Memo

备注/Memo:
[基金项目]河北省自然科学基金资助项目(H2021423030); 河北省中医药管理局计划项目(2022332,2019024)
更新日期/Last Update: 2025-04-08